Product Image

Maximum Omega Minis Natural Lemon Flavor

Carlson
4.9
★ ★ ★ ★ ★
(1209 ratings)
EPA (Eicosapentaenoic Acid) 600 mg
Omega-3 1000 mg
DHA 400 mg
Marine oil (unspecified) 1250 mg
Product Image
Score76
A concentrated, clearly dosed EPA-and-DHA formula in smaller softgels, held back mainly by missing molecular-form and freshness details.
How scoring works
Quantity:120 Softgel(s) • (60 servings)
Goals:
Heart Health
Skin Health
Metabolism Boost
Joint Health
Mental Focus

Score 76

A concentrated, clearly dosed EPA-and-DHA formula in smaller softgels, held back mainly by missing molecular-form and freshness details.
How scoring works
$55.25($0.92 per serving)
Pure Formulas
$ 55.25
iHerb
$ 55.25
iHerb
$ 55.25
Report prices

Analysis

The EPA and DHA amounts provide meaningful support for heart health, with additional relevance to skin and joints. DHA also contributes to brain structure, though the serving is more EPA-heavy than a DHA-focused cognitive product.

Total marine oil, total omega-3s, EPA, and DHA are all clearly disclosed, showing a high concentration of active fatty acids. The label does not identify the molecular form or provide freshness and oxidation markers, so absorption and oil condition cannot be compared precisely.

Adults who want a concentrated dose in smaller softgels may find the format easier to take than large fish-oil capsules. Budget-focused users or people needing a DHA-led formula may prefer a different EPA-to-DHA balance.

Who is it for
  • Adults seeking concentrated heart-focused omega-3 support
  • People who prefer smaller lemon-flavored softgels
Best for
  • EPA-forward cardiovascular support
  • Combined skin and joint omega-3 support

Pros

  • High proportion of omega-3s in the marine oil
  • EPA and DHA are listed separately
  • Meaningful combined EPA and DHA amount
  • Mini-softgel format may improve swallowing

Cons

  • Molecular form is not stated
  • No oxidation or freshness markers are provided
  • DHA amount is lower than EPA
  • Serving cost is higher than basic fish oil

Warnings

  • Fish-derived oil is unsuitable for people with fish allergy
  • Omega-3s may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines
  • The oil may cause fishy burps or digestive upset
  • Discuss high total omega-3 intake before planned surgery

Nutrient quality

85 Highest impact

A substantial EPA-forward omega-3 amount provides meaningful depth for the intended uses. Missing molecular form, source, and oxidation-protection details limit quality confidence despite the focused formula.

Ingredient transparency

80 Highest impact

EPA and DHA have clear amounts, and no blend hides the key fatty-acid doses. Source, molecular-form, daily-direction, and inactive-ingredient details remain incomplete.

Customer satisfaction

73 High impact

The supplied aggregate rating is favorable and supported by a very large review volume. Detailed feedback is unavailable, so repeated complaints and fit with the intended use cannot be judged.

Value for money

63 Moderate impact

The formula provides moderate practical value for its key fatty-acid content. The focused active profile preserves category competitiveness.

Report analysis

Goals

Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 600 mg

A fully disclosed 600 mg of EPA and 400 mg of DHA provides a concentrated omega-3 serving with strong heart-health relevance. The balanced profile supports triglyceride management, inflammatory balance, and cell-membrane function.

The marine-oil amount and individual fatty acids are clear, although the triglyceride or ethyl ester form is not identified. EPA and DHA may modestly increase bleeding tendency with anticoagulant or antiplatelet medicines, especially alongside other products that affect clotting.

Study evidence
Skin Health
Skin Health
Impact
Highest effect
B Goal FitA- Strength of SupportC CoverageA+ Formula Quality
Omega-3 · 1000 mg

EPA and DHA provide targeted lipid support for the skin barrier and may help regulate inflammatory responses. Their individual amounts are fully disclosed and substantial.

The marine-oil concentrate delivers a strong active-fatty-acid proportion, though molecular form, antioxidant protection, and independent purity testing are not supplied. The focused formula lacks collagen or dedicated hydration actives but provides excellent depth in its chosen pathway.

Study evidence
Omega-3 Supportive 35 studies
Metabolism Boost
Metabolism Boost
Impact
High effect
B Goal FitB+ Strength of SupportC+ CoverageA Formula Quality
Omega-3 · 1000 mg

Omega-3 fatty acids support insulin signaling, cell-membrane function, and metabolic health through reduced inflammatory strain. The 1000 mg serving is substantial, but the effect is supportive rather than a direct increase in thermogenesis.

EPA and DHA amounts are transparent, while source, molecular form, purification, and independent testing remain undisclosed. No stimulant, thyroid nutrient, or mitochondrial transport active is included, so pathway coverage remains moderate.

Study evidence
Omega-3 Supportive 42 studies
Joint Health
Joint Health
Impact
High effect
B- Goal FitA- Strength of SupportC- CoverageA Formula Quality
Omega-3 · 1000 mg

Clearly disclosed EPA and DHA provide a meaningful anti-inflammatory fatty-acid approach to joint comfort. Human evidence suggests marine omega-3s may help symptoms in some inflammatory joint settings, though they do not rebuild cartilage.

The concentrated serving offers good depth in one pathway rather than broad joint coverage. Precise active-fatty-acid amounts strengthen dose confidence, while no structural or lubrication ingredient is included.

Study evidence
Omega-3 Supportive 40 studies
Mental Focus
Mental Focus
Impact
High effect
C Goal FitB+ Strength of SupportD CoverageB+ Formula Quality

EPA and DHA provide long-term support for brain structure and a healthy inflammatory balance, but they are not direct acute focus enhancers. The disclosed amounts are substantial and may support the conditions needed for steady cognition over time.

The formula does not address alertness, neurotransmitter production, or stress resilience with dedicated focus ingredients. Exact fatty-acid amounts are helpful, although the oil form and oxidation-quality details are not provided.

Study evidence

Ingredients

IngredientAmount per serving
Calories
15 Calorie(s)
Total Fat
1.5 Gram(s)
Marine Oil concentrate
1250 mg
Total Omega-3 Fatty Acids
1000 mg
Eicosapentaenoic Acid
600 mg
Docosahexaenoic Acid
400 mg
Gluten Free Adults 18–50
Report overview
EPA (Eicosapentaenoic Acid) · 600 mg OverallScore57
D Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyD+ Value

The molecular form is unspecified; ePA density is moderately concentrated, and no protective antioxidant is listed. The serving provides a strong EPA amount with a clearly EPA-centric ratio. No purification or third-party verification is shown, while normalized cost is moderate.

View ingredientView products
Omega-3 · 1000 mg OverallScore56
D- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyD+ Value

EPA and DHA are fully disclosed and together make up most of the marine-oil concentrate. The concentrate form suggests moderate absorption, while source detail, antioxidant protection, and independent testing are not supplied. The cost per active amount is moderate rather than especially economical.

View ingredientView products
DHA · 400 mg OverallScore34
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

The DHA chemical form is not identified, leaving bioavailability uncertain. The 400 mg DHA serving provides a moderate amount. No protective antioxidant is listed, and generic marine oil lacks explicit third-party purity verification.

View ingredientView products
Loading alternative details
86 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
A formulation advantage for the right user over Maximum Omega Minis Natural Lemon Flavor is a highly concentrated 1,100 mg triglyceride omega-3 serving with clear EPA and DHA amounts. Molecular distillation adds purity assurance, though fish species, antioxidant protection, and independent testing are not stated.
86 Performance

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
A formulation advantage for the right user over Maximum Omega Minis Natural Lemon Flavor is a substantial serving with EPA and DHA stated separately. The ethyl-ester form is less readily absorbed than triglyceride oil, and oxidation protection plus independent testing are not supplied.
85 Performance

Wild Alaskan Fish Oil Peak EPA

Wiley's Finest
A formulation advantage for the right user over Maximum Omega Minis Natural Lemon Flavor is a concentrated EPA-heavy serving with individual fatty-acid amounts clearly stated. Molecular form, oxidation protection, purification, and independent testing remain unspecified.
79 Budget

Fish Oil 1000 mg

Mason Natural
Lower recurring cost is the clearest advantage over Maximum Omega Minis Natural Lemon Flavor, while the formula provides clearly disclosed EPA and DHA in a basic fish-oil softgel. The active omega-fat amount is low, and source, molecular form, oxidation protection, and purity testing are not supplied.
82 Budget

Omega 3 Fish Oil Concentrate

Solgar
Lower recurring cost is the clearest advantage over Maximum Omega Minis Natural Lemon Flavor, while the formula provides a modest, clearly disclosed EPA and DHA serving for routine use. Low concentration plus missing molecular-form, source, oxidation, and purity details limit quality confidence.
69 Budget

Kid's Chewable DHA 100 mg Bursting Orange Flavor!

Carlson
Lower recurring cost is the clearest advantage over Maximum Omega Minis Natural Lemon Flavor, while the formula provides triglyceride fish oil and vitamin E in a child-friendly chewable with 100 mg DHA. The active omega-3 amount and oil concentration are low, and independent purity testing is not supplied.
84 Value

Omega-3 Fish Oil 1250 mg

SR Sports Research
Lower recurring cost paired with a highly concentrated EPA-led fish-oil serving in one softgel creates a useful value trade-off versus Maximum Omega Minis Natural Lemon Flavor. Molecular form, purification, antioxidant protection, fish species, and independent testing are not supplied.
84 Value

Fish Oil 1400 mg

Nature's Bounty
Lower recurring cost paired with a meaningful EPA-led amount with strong oil concentration creates a useful value trade-off versus Maximum Omega Minis Natural Lemon Flavor. The ethyl-ester form is less readily absorbed, and fish source, antioxidant protection, and independent testing are not stated.
84 Value

Omega 3 Fish Oil Concentrate

Solgar
Lower recurring cost paired with triglyceride fish oil with individual fatty acids clearly disclosed creates a useful value trade-off versus Maximum Omega Minis Natural Lemon Flavor. Active concentration is modest, while source, oxidation protection, and independent purity details are missing.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  3. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  5. Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease.
    Toyama K; Nishioka T; Isshiki A; Ando T; Inoue Y; Kirimura M; Kamiyama T; Sasaki O; Ito H; Maruyama Y; Yoshimoto N · Cardiovascular drugs and therapy · 2014
    Randomized trial80 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  6. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.
    Satoh N; Shimatsu A; Kotani K; Himeno A; Majima T; Yamada K; Suganami T; Ogawa Y · Hypertension research : official journal of the Japanese Society of Hypertension · 2010
    Randomized trial92 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  7. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.
    Innes JK; Calder PC · International journal of molecular sciences · 2018
    Systematic review527 participants6 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  8. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A · The American journal of clinical nutrition · 1997
    Randomized trial234 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  9. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  10. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  11. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  12. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  13. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  14. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  15. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  16. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  17. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  18. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  19. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  20. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  21. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  22. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  23. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  24. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  25. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  26. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  27. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  28. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  29. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  30. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3